Metabolomics Workbench : NIH Data Repository : Analyze Studies

Data for ST004205

(Analysis AN006992): Average values per metabolite and experimental factor (Units:normalized peak area)

Metabolite structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10
1-O-Palmitoyl-Cer(d18:1/18:0)	-	-	-	-	-	-	-	-	-	-
24-Hydroxycholesterol	-	-	-	-	-	-	-	-	-	-
24-Hydroxycholesterol(d7)	-	-	-	-	-	-	-	-	-	-
3-O-SulfoLacCer(d18:1/18:0)	-	-	-	-	-	-	-	-	-	-
4-beta-Hydroxycholesterol	-	-	-	-	-	-	-	-	-	-
7-keto-Cholesterol	-	-	-	-	-	-	-	-	-	-
CE(16:1)	0.09	0.02	0.03	0.05	0.02	0.08	0.20	0.02	0.23	0.02
CE(18:1)	1.36	0.19	0.21	0.59	0.17	1.03	3.54	0.18	4.17	0.19
CE(18:1(d7))	-	-	-	-	-	-	-	-	-	-
CE(18:2)	0.72	0.17	0.24	0.38	0.12	0.53	1.50	0.13	1.46	0.15
CE(20:4)	6.83	0.50	0.66	3.50	0.28	3.32	15.04	0.39	7.78	0.42
CE(20:5)	6.68	0.19	0.19	2.68	0.08	1.95	12.29	0.11	4.76	0.12
CE(22:6)	8.48	0.23	0.22	2.62	0.09	3.16	14.76	0.12	12.40	0.18
CE HETE	-	-	-	-	-	-	-	-	-	-
CE HODE	-	-	-	-	-	-	-	-	-	-
CE HpODE	-	-	-	-	-	-	-	-	-	-
CE oxoHETE	-	-	-	-	-	-	-	-	-	-
CE oxoODE	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/16:0)	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/18:0)	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/24:0)	-	-	-	-	-	-	-	-	-	-
Cer(d18:0/24:1)	-	-	-	-	-	-	-	-	-	-
Cer(d18:1/16:0)	7.73	6.54	5.12	5.97	3.34	5.05	8.06	3.54	6.08	3.96
Cer(d18:1/16:0(d7))	-	-	-	-	-	-	-	-	-	-
Cer(d18:1/18:0)	6.51	2.48	1.58	5.80	1.16	2.92	6.32	1.25	6.56	0.76
Cer(d18:1/24:0)	19.41	19.53	10.66	12.34	5.89	9.70	17.15	6.19	11.09	4.82
Cer(d18:1/24:1)	31.41	13.41	10.02	27.33	6.68	16.50	31.28	6.23	28.80	6.33
Cholesterol	5.39	4.50	2.68	5.59	1.91	3.17	4.11	1.66	4.37	2.19
Cholesterol(d7)	-	-	-	-	-	-	-	-	-	-
Cholesteryl hexoside	0.02	0.01	0.00	0.01	0.00	0.01	0.03	0.00	0.02	0.00
Coenzyme Q10	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00
DG(15:0/18:1(d7))	-	-	-	-	-	-	-	-	-	-
DG(16:0_18:1)	1.47	1.13	0.71	1.54	0.42	0.98	1.07	0.44	1.42	0.78
DG(16:0_20:4)	0.44	0.27	0.20	0.66	0.10	0.25	0.36	0.12	0.31	0.12
DG(18:0_18:1)	1.11	0.43	0.30	1.79	0.28	0.65	1.00	0.29	0.82	0.32
DG(18:0_20:4)	1.65	0.38	0.25	2.92	0.14	0.79	1.48	0.13	1.17	0.16
DG(18:0_22:6)	0.08	0.11	0.64	0.29	0.38	0.40	0.59	0.39	0.64	0.35
DG(18:1/18:1)	1.22	0.69	0.50	1.30	0.21	0.79	0.88	0.21	1.69	0.72
DG(18:1_20:4)	0.37	0.20	0.15	0.49	0.06	0.21	0.28	0.06	0.38	0.13
GB3(d18:1/16:0)	0.06	0.07	0.04	0.03	0.02	0.03	0.03	0.03	0.03	0.02
GB3(d18:1/18:0)	0.02	0.02	0.01	0.01	0.01	0.01	0.02	0.01	0.01	0.01
GB3(d18:1/18:0(d3))	-	-	-	-	-	-	-	-	-	-
GB3(d18:1/24:0)	0.06	0.07	0.03	0.04	0.03	0.04	0.07	0.04	0.02	0.02
GB3(d18:1/24:1)	0.10	0.10	0.07	0.06	0.05	0.07	0.11	0.08	0.06	0.05
GlcCer(d18:1/16:0(d3))	-	-	-	-	-	-	-	-	-	-
GlcCer(d18:1(d5)/18:0)	-	-	-	-	-	-	-	-	-	-
Glucosylsphingosine(d5)	-	-	-	-	-	-	-	-	-	-
HexCer(d18:1/12:0)	-	-	-	-	-	-	-	-	-	-
HexCer(d18:1/16:0)	2.35	2.48	1.62	1.87	1.48	1.84	2.08	1.42	2.29	2.14
HexCer(d18:1/18:0)	5.75	1.14	0.66	5.68	0.69	2.54	5.76	0.66	6.55	0.63
HexCer(d18:1/22:0)	11.09	6.25	3.65	9.62	3.41	5.92	11.25	3.83	9.32	1.79
HexCer(d18:1/24:0)	18.52	9.40	5.43	15.19	4.94	9.51	17.96	5.32	16.41	2.34
HexCer(d18:1/24:1)	32.33	9.19	5.52	30.33	5.30	17.03	32.39	4.88	32.94	3.92
Hexosylsphingosine	-	-	-	-	-	-	-	-	-	-
LacCer(d18:1/16:0)	0.10	0.06	0.06	0.11	0.08	0.10	0.16	0.08	0.23	0.16
LacCer(d18:1/17:0)	-	-	-	-	-	-	-	-	-	-
LacCer(d18:1/18:0)	0.05	0.01	0.01	0.05	0.01	0.03	0.07	0.01	0.07	0.02
LacCer(d18:1/24:0)	0.09	0.07	0.04	0.07	0.04	0.06	0.10	0.04	0.09	0.04
LacCer(d18:1/24:1)	0.10	0.05	0.03	0.08	0.03	0.07	0.12	0.03	0.15	0.06
Lactosylsphingosine	-	-	-	-	-	-	-	-	-	-
LPC(16:0)	0.53	0.30	0.34	0.77	0.33	0.39	0.67	0.34	0.30	0.12
LPC(16:1)	0.01	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
LPC(18:0)	1.07	0.54	0.62	1.55	0.67	0.75	1.25	0.65	0.63	0.25
LPC(18:1)	0.23	0.15	0.15	0.30	0.14	0.17	0.25	0.14	0.19	0.09
LPC(18:1(d7))	-	-	-	-	-	-	-	-	-	-
LPC(20:4)	0.05	0.07	0.05	0.04	0.04	0.05	0.06	0.06	0.03	0.02
LPC(22:6)	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
LPC(24:0)	0.07	0.02	0.01	0.04	0.01	0.03	0.07	0.01	0.06	0.00
LPC(24:1)	0.04	0.01	0.01	0.03	0.01	0.02	0.04	0.00	0.04	0.00
LPC(26:0)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
LPC(26:1)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lyso-GB3	-	-	-	-	-	-	-	-	-	-
lyso-GB3-d7	-	-	-	-	-	-	-	-	-	-
lyso-GB4	-	-	-	-	-	-	-	-	-	-
MG(16:0)	140.70	126.05	137.78	167.03	143.45	159.98	182.26	138.43	165.91	150.19
MG(16:1)	-	-	-	-	-	-	-	-	-	-
MG(18:0)	552.68	518.99	497.67	661.15	548.36	581.97	685.99	570.55	621.62	592.91
MG(18:1)	19.94	18.48	16.89	23.56	19.31	21.59	24.16	19.33	23.55	21.08
MG(18:1(d7))	-	-	-	-	-	-	-	-	-	-
MG(20:4)	-	-	-	-	-	-	-	-	-	-
N-Oleoylethanolamine	-	-	-	0.00	0.00	-	-	0.00	0.00	0.00
N-Palmitoyl-O-phosphocholineserine	-	-	-	-	-	-	-	-	-	-
Palmitoylethanolamine	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00
PC(15:0/18:1(d7))	-	-	-	-	-	-	-	-	-	-
PC(16:0/5:0(CHO))	0.00	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.00	0.00
PC(16:0/9:0(CHO))	0.03	0.03	0.03	0.02	0.02	0.03	0.02	0.02	0.03	0.03
PC(16:0/9:0(COOH))	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PC(18:0/20:4(OH[S]))	-	-	-	-	-	-	-	-	-	-
PC(18:0/20:4(OOH[S]))	-	-	-	-	-	-	-	-	-	-
PC(34:1)	5.00	4.94	4.01	4.39	3.19	4.20	4.22	3.15	4.68	4.21
PC(36:1)	3.64	2.16	1.46	3.33	1.02	2.39	3.24	1.08	3.40	1.24
PC(36:2)	3.88	3.68	2.47	2.81	1.69	2.93	2.66	1.57	4.45	3.48
PC(36:4)	3.73	4.09	3.28	3.64	3.33	3.34	3.59	3.20	2.46	2.10
PC(38:4)	2.05	2.41	1.70	1.96	1.78	1.75	1.94	1.66	1.00	0.74
PC(38:6)	0.96	1.17	0.66	0.63	0.42	0.58	0.51	0.32	0.61	0.48
PC(40:5)	0.54	0.58	0.38	0.44	0.33	0.38	0.41	0.33	0.28	0.22
PC(40:6)	0.60	0.60	0.41	0.46	0.29	0.38	0.36	0.23	0.40	0.26
PC(O-16:0/0:0)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PC(O-16:0/2:0)	0.05	0.04	0.05	0.04	0.04	0.05	0.07	0.05	0.05	0.03
PC(O-18:0/2:0)	0.02	0.01	0.01	0.02	0.01	0.01	0.02	0.01	0.01	0.00
PE(15:0/18:1(d7))	-	-	-	-	-	-	-	-	-	-
PE(18:0/20:4(OH[S]))	-	-	-	-	-	-	-	-	-	-
PE(18:0/20:4(OOH[S]))	-	-	-	-	-	-	-	-	-	-
PE(34:1)	9.86	10.42	6.09	8.27	3.51	6.51	5.60	2.85	9.28	8.01
PE(36:1)	27.36	23.63	14.46	22.25	9.62	16.82	19.00	9.24	25.42	15.83
PE(36:2)	15.11	11.13	6.14	15.14	3.82	9.37	9.75	2.85	16.46	12.38
PE(36:4)	3.15	3.80	2.05	2.81	1.69	2.02	1.91	1.34	1.82	1.44
PE(38:4)	26.01	32.85	20.43	20.46	16.61	19.79	18.26	14.85	18.80	17.16
PE(38:5)	6.12	5.91	3.23	5.66	2.42	3.76	3.92	1.93	4.84	3.59
PE(38:6)	3.31	5.00	2.73	2.82	1.95	2.25	1.57	1.30	1.93	1.93
PE(40:4)	6.74	9.72	5.44	4.31	3.34	4.67	3.56	3.60	4.70	4.43
PE(40:5)	-	-	-	-	-	-	-	-	-	-
PE(40:6)	8.37	10.99	6.38	6.26	4.07	5.73	4.24	3.21	6.08	5.69
PE(40:7)	2.98	4.26	2.49	1.99	1.49	2.28	1.16	1.02	3.07	3.72
Sitosteryl hexoside	-	-	-	-	-	-	-	-	-	-
SM(d18:1/16:0)	6.37	7.58	5.62	4.61	4.31	5.50	4.34	3.93	6.72	6.95
SM(d18:1/18:0)	2.62	2.97	1.85	2.02	1.27	1.89	1.71	1.07	2.57	1.85
SM(d18:1/24:0)	4.36	5.40	3.11	2.41	1.73	2.89	2.33	1.51	3.26	2.25
SM(d18:1/24:1)	8.17	9.73	6.49	5.60	4.22	6.30	4.95	3.32	7.76	6.42
SM(d18:1(d9)/18:1)	-	-	-	-	-	-	-	-	-	-
Sphinganine	-	-	-	-	-	-	-	-	-	-
Sphinganine 1-phosphate	0.11	0.01	0.01	0.03	0.00	0.03	0.09	0.00	0.16	0.01
Sphingosine	18.35	1.43	1.23	10.02	0.77	7.13	20.33	1.06	24.39	0.94
Sphingosine 1-phosphate	0.09	0.01	0.01	0.03	0.00	0.03	0.08	0.01	0.11	0.01
Sphingosine 1-phosphate-d7	-	-	-	-	-	-	-	-	-	-
Sphingosine 1-phosphocholine	-	-	-	-	-	-	-	-	-	-
Sphingosine(d17:1)	-	-	-	-	-	-	-	-	-	-
TG(15:0/18:1(d7)/15:0)	-	-	-	-	-	-	-	-	-	-
TG(18:0_36:2)	0.49	0.24	0.16	0.21	0.07	0.29	0.41	0.11	0.81	0.22
TG(18:1_34:2)	0.88	0.68	0.44	0.26	0.14	0.62	0.44	0.14	1.64	1.02
TG(18:1_34:3)	0.14	0.16	0.09	0.03	0.02	0.10	0.04	0.02	0.26	0.23
TG(20:4_32:1)	0.10	0.10	0.07	0.03	0.02	0.06	0.03	0.02	0.10	0.11
TG(20:4_34:2)	0.09	0.09	0.06	0.02	0.02	0.05	0.03	0.02	0.10	0.11
TG(20:4_34:3)	0.02	0.03	0.02	0.00	0.01	0.01	0.00	0.01	0.01	0.02
TG(20:4_36:0)	0.07	0.04	0.03	0.03	0.01	0.03	0.05	0.02	0.08	0.02
TG(20:4_36:2)	0.26	0.14	0.12	0.08	0.03	0.14	0.13	0.05	0.35	0.20
TG(20:4_36:3)	0.10	0.09	0.07	0.04	0.02	0.06	0.04	0.03	0.08	0.09
TG(22:6_36:2)	0.14	0.05	0.03	0.03	0.01	0.07	0.05	0.01	0.31	0.08
TG(22:6_38:1)	0.01	0.00	0.00	0.00	0.00	0.01	0.01	0.00	0.02	0.00
TG(22:6_38:2)	0.02	0.00	0.00	0.01	0.00	0.01	0.01	0.00	0.04	0.01

Factors:

F1	Genotype:GPR34-KO \| Treatment:Myelin \| Sample source:iMicroglia
F2	Genotype:GPR34 KO \| Treatment:PBS \| Sample source:iMicroglia
F3	Genotype:GPR34-KO \| Treatment:PBS \| Sample source:iMicroglia
F4	Genotype:GPR34/TREM2-KO \| Treatment:Myelin \| Sample source:iMicroglia
F5	Genotype:GPR34/TREM2-KO \| Treatment:PBS \| Sample source:iMicroglia
F6	Genotype:NA \| Treatment:NA \| Sample source:iMicroglia
F7	Genotype:TREM2-KO \| Treatment:Myelin \| Sample source:iMicroglia
F8	Genotype:TREM2-KO \| Treatment:PBS \| Sample source:iMicroglia
F9	Genotype:WT \| Treatment:Myelin \| Sample source:iMicroglia
F10	Genotype:WT \| Treatment:PBS \| Sample source:iMicroglia